PD-1 Inhibitors Plus Capecitabine as Maintenance Therapy for Advanced Intrahepatic Cholangiocarcinoma: A Case Report and Review of Literature

Intrahepatic cholangiocarcinoma (iCCA) is the second most common primary liver cancer with a poor prognosis. Recently, an immunotherapy strategy represented by programmed cell death 1 (PD-1) inhibitors has been applied to the systemic treatment of advanced iCCA. However, immunotherapy combined with...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zhihong, Zeng, Tianmei, Li, Yong, Zhang, Ding, Yuan, Zhengang, Huang, Mengli, Yang, Yuan, Zhou, Weiping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8739978/
https://www.ncbi.nlm.nih.gov/pubmed/35003124
http://dx.doi.org/10.3389/fimmu.2021.799822

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8739978/
https://www.ncbi.nlm.nih.gov/pubmed/35003124
http://dx.doi.org/10.3389/fimmu.2021.799822

Ejemplares similares